Michael Kasperkiewicz (M Kasperkiewicz)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Systematic Review

Coronavirus Disease

Hodgkin Lymphoma

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Experimental dermatology

Cell stress & chaperones

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Kasperkiewicz, N Elbuluk, B T Ngo, Khalaf Kridin, R J Ludwig
Differing features of pemphigus in skin of colour versus white skin: A broad-scale cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Michael Kasperkiewicz, Jerzy W Kupiec-Weglinski, Binh T Ngo, Khalaf Kridin, Ralf J Ludwig
Risk of de novo bullous pemphigoid and pemphigus following transplantation: A global wide-scale cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Michael Kasperkiewicz, David T Woodley
Rituximab in immunobullous disorders during the COVID-19 pandemic: A systematic review of observational studies. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Michael Kasperkiewicz, D T Woodley
Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (7) (2022)
Michael Kasperkiewicz
Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
Michael Kasperkiewicz, Rebecca Strong, Marc Yale, Patrick Dunn, David T Woodley
A cross-sectional study of dermatologists' attitudes towards COVID-19 vaccination in patients with immunobullous diseases. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Michael Kasperkiewicz, Rebecca Strong, Marc Yale, Patrick Dunn, David T Woodley
Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Michael Kasperkiewicz, R Strong, M Yale, P Dunn, D T Woodley
Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
Michael Kasperkiewicz, M Yale, R Strong, D Zillikens, D T Woodley, A Recke
COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
Michael Kasperkiewicz, Enno Schmidt, M Amagai, J A Fairley, Pascal Joly, D F Murrell, A S Payne, M L Yale, D Zillikens, D T Woodley
Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
Michael Kasperkiewicz, E Schmidt, J A Fairley, Pascal Joly, A S Payne, M L Yale, D Zillikens, D T Woodley
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (7) (2020)
Michael Kasperkiewicz
Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention. Cell stress & chaperones 26 (1) (2020)
Katja Bieber, Anna Lara Ernst, Stefan Tukaj, Maike M Holtsche, Enno Schmidt, Detlef Zillikens, Pardis-Sadat Tabatabaei-Panah, Michael Kasperkiewicz
Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid. Experimental dermatology 26 (12) (2017)